{"id":9370,"date":"2026-09-30T17:57:10","date_gmt":"2026-09-30T17:57:10","guid":{"rendered":"https:\/\/aptechka.store\/?post_type=product&p=9370"},"modified":"2026-09-30T21:52:29","modified_gmt":"2026-09-30T21:52:29","slug":"buy-actovegin-200mg-pills-usa","status":"publish","type":"product","link":"https:\/\/aptechka.store\/ru\/shop\/buy-actovegin-200mg-pills-usa\/","title":{"rendered":"Actovegin 200 mg 50 tablets | Tissue Metabolism Booster | Enhances Brain Oxygenation & Glucose Uptake"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

FDA DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration (FDA). If you are searching to buy actovegin 200mg pills usa, please note that Aptechka.store provides 100% original Actovegin 200 mg 50 tablets | Tissue Metabolism Booster | Enhances Brain Oxygenation & Glucose Uptake for personal use. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your attending physician strictly before starting any new protocol.<\/a><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t
Directions: <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Actovegin 200 mg is a film-coated tablet formulation containing a deproteinized hemoderivative of calf blood as its active substance. It belongs to the pharmacotherapeutic group of **tissue regeneration stimulators** and is used as part of combination therapy for cognitive, peripheral circulatory, and diabetic neuropathic conditions. If you are looking to **buy Actovegin 200mg pills USA**, this summary covers the essential prescribing information you should review first.<\/p>

\ud83d\udccb Indications<\/p>

Used as part of combination therapy:
* **Symptomatic treatment of cognitive disorders**, including post-stroke cognitive impairment and dementia.
* **Symptomatic treatment of peripheral circulatory disorders** and their consequences.
* **Symptomatic treatment of diabetic polyneuropathy (DPN).**<\/p>

\ud83d\udc8a Composition<\/p>

1 film-coated tablet contains:
* **Core**: Active substance: blood components: deproteinized hemoderivative of calf blood \u2013 200.0 mg (in the form of Actovegin granulate* \u2013 345.0 mg). Excipients: magnesium stearate \u2013 2.0 mg, talc \u2013 3.0 mg.
* **Coating**: acacia gum \u2013 6.8 mg, glyceryl montanate wax \u2013 0.1 mg, hypromellose phthalate \u2013 29.45 mg, diethyl phthalate \u2013 11.8 mg, quinoline yellow aluminum lake dye \u2013 2.0 mg, macrogol-6000 \u2013 2.95 mg, povidone-K30 \u2013 1.54 mg, sucrose \u2013 52.3 mg, talc \u2013 42.2 mg, titanium dioxide \u2013 0.86 mg.<\/p>

*Actovegin granulate contains: active substance: blood components: deproteinized hemoderivative of calf blood \u2013 200.0 mg; excipients: povidone-K90 \u2013 10.0 mg, microcrystalline cellulose \u2013 135.0 mg.<\/p>

\ud83d\udca7 Dosage and Administration<\/p>

Administered **orally**, without chewing, **before meals**, with a small amount of liquid.<\/p>

* **Post-stroke cognitive impairment**: In the acute period of ischemic stroke, starting from day 5\u20137, **2000 mg per day intravenously by drip** for up to 20 infusions, followed by a switch to the tablet form at **2 tablets 3 times daily (1200 mg\/day)**. Total duration of treatment: **6 months**.
* **Dementia**: **2 tablets 3 times daily (1200 mg\/day)**. Total duration of treatment: **20 weeks**.
* **Peripheral circulatory disorders and their consequences**: **1\u20132 tablets 3 times daily (600\u20131200 mg\/day)**. Duration of treatment: **4 to 6 weeks**.
* **Diabetic polyneuropathy**: **2000 mg per day intravenously by drip** for 20 infusions, followed by a switch to the tablet form at **3 tablets 3 times daily (1800 mg\/day)**; duration: **4 to 5 months**.<\/p>

Patients who decide to **buy Actovegin 200mg pills USA** should follow the prescribed regimen strictly, since the dosing differs significantly between indications.<\/p>

\u26a0\ufe0f Contraindications<\/p>

* Hypersensitivity to Actovegin\u00ae and similar drugs or to any excipients.
* Fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency.
* Children and adolescents **under 18 years of age**.<\/p>

**With caution**: Pregnancy and breastfeeding.<\/p>

\ud83e\udd30 Use in Pregnancy and Breastfeeding<\/p>

Actovegin should be used only when the therapeutic benefit outweighs the potential risk to the fetus or infant.<\/p>

\ud83d\udccc Special Precautions<\/p>

**Clinical data**: In the multicenter, randomized, double-blind, placebo-controlled ARTEMIDA study (NCT01582854), which aimed to evaluate the therapeutic effect of Actovegin\u00ae on cognitive impairment in 503 patients with ischemic stroke, the overall incidence of serious adverse events and death was the same in both treatment groups. Although the rate of recurrent ischemic strokes was within the range expected in this patient population, a higher number of cases was recorded in the Actovegin\u00ae group compared with the placebo group; however, this difference was statistically non-significant. No causal relationship between recurrent stroke cases and the study drug was established.<\/p>

**Use in pediatric patients**: Currently, there are no data on the use of Actovegin in children; therefore, its use in this population is not recommended.<\/p>

**Effect on ability to drive and operate machinery**: Not established.<\/p>

\ud83d\udce6 Packaging and Dosage Form<\/p>

Film-coated tablets, 200 mg \u2013 50 tablets per pack.<\/p>

**Description**: Round, biconvex, film-coated tablets of a greenish-yellow color, glossy.<\/p>

\u26a1 Side Effects<\/p>

The frequency of adverse effects was determined according to the Council for International Organizations of Medical Sciences (CIOMS) classification: very common (> 1\/10); common (> 1\/100 to < 1\/10); uncommon (> 1\/1000 to < 1\/100); rare (> 1\/10000 to < 1\/1000); very rare (< 1\/10000); unknown (cannot be estimated from available data).<\/p>

* **Immune system disorders** \u2013 Rare: allergic reactions (drug fever, shock symptoms).
* **Skin and subcutaneous tissue disorders** \u2013 Rare: urticaria, sudden flushing.<\/p>

\u00a0\ud83d\udd04 Interaction with Other Medicinal Products<\/p>

Currently unknown.<\/p>

\ud83e\uddec Pharmacodynamics<\/p>

Actovegin\u00ae is an **antihypoxant** that produces three types of effects: metabolic, neuroprotective, and microcirculatory.<\/p>

Actovegin increases oxygen uptake and utilization; the inositol phospho-oligosaccharides contained in the drug positively influence glucose transport and utilization, which leads to improved cellular energy metabolism and reduced lactate formation under ischemic conditions.<\/p>

Several pathways are considered for the neuroprotective mechanism of action. Actovegin prevents apoptosis induced by beta-amyloid peptide (A\u03b2(25\u201335)). Actovegin modulates the activity of nuclear factor kappa B (NF-\u03baB), which plays an important role in regulating apoptosis and inflammation in the central and peripheral nervous system. Another mechanism is associated with the nuclear enzyme poly(ADP-ribose) polymerase (PARP). PARP plays an important role in detecting and repairing single-strand DNA damage; however, excessive activation of the enzyme can trigger cell death processes in conditions such as cerebrovascular diseases and diabetic polyneuropathy. Actovegin inhibits PARP activity, resulting in functional and morphological improvement of the central and peripheral nervous system.<\/p>

The positive effects of Actovegin on microcirculation and the endothelium include increased capillary blood flow velocity, reduced pericapillary zone, decreased myogenic tone of precapillary arterioles and capillary sphincters, reduced arteriovenous shunting with predominant capillary blood flow, and stimulation of endothelial nitric oxide synthase function affecting the microvascular bed.<\/p>

Various studies have established that the effect of Actovegin occurs no later than 30 minutes after administration. The maximum effect is observed 3 hours after parenteral administration and 2\u20136 hours after oral administration. Those who **buy Actovegin 200mg pills USA** for oral use should expect the peak effect within this 2\u20136 hour window.<\/p>

\ud83c\udf21\ufe0f Storage Temperature<\/p>

From 2 \u00b0C to 25 \u00b0C.<\/p>

\ud83e\uddea Pharmacokinetics<\/p>

Pharmacokinetic parameters of Actovegin cannot be studied using pharmacokinetic methods, since it consists solely of physiological components normally present in the body.<\/p>

\ud83d\udea8 Overdose<\/p>

According to preclinical studies, Actovegin does not exhibit toxic effects even when the dose is exceeded 30\u201340 times compared with doses recommended for human use. No cases of Actovegin overdose have been reported.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t

\n\t\t\t\t\n\t\t\t\t\t
References: <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Gulevsky, Alexander Kirillovich; Abakumova, Yelena Sergeevna; Moiseyeva, Natalya Nikolaevna; Ivanov, Yevgeniy Gennadievich (2011). «Influence of Cord Blood Fraction (below 5 kDa) on Reparative Processes during Subchronic Ulcerative Gastropathy»<\/a>.\u00a0Ulcers<\/i>.\u00a02011<\/b>:\u00a01\u2013<\/span>9.\u00a0doi<\/a>:10.1155\/2011\/214124<\/a><\/span>.<\/cite><\/span><\/span><\/li>
  2. <\/a><\/span>\u00a0Dopingfund in G\u00f6teborg, Polizei stellt Ermittlungen ein<\/a><\/span><\/li>
  3. <\/a><\/span>\u00a0The doctor they call ‘Healing Hans’<\/a>, ESPN, 2011-12-16.<\/span><\/li>
  4. Fish, Mike (December 16, 2011). «Anthony Galea receives no jail time»<\/a>.\u00a0ESPN<\/i>. Retrieved\u00a0December 16,<\/span>\u00a02011<\/span>.<\/cite><\/span><\/span><\/li>
  5. <\/a><\/span>\u00a0Doheny, Kathleen. «FAQ on Actovegin: An Expert Explains How the Drug May Enhance Athletic Performance.» WebMD Health News. December 16, 2009.<\/a>\u00a0Accessed 2011-09-16.<\/span><\/li>
  6. Schmidt, Michael S.; Austen, Ian (2009-12-17). «Doctor Under Investigation Is Charged in Canada»<\/a>.\u00a0The New York Times<\/i>. Retrieved\u00a02009-12-17<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  7. <\/a><\/span>\u00a0Canadian regulatory body suspends Dr. Anthony Galea for nine months following U.S. sports doping scandal<\/a>, Daily News, 2017-12-06.<\/span><\/li>
  8. «Former Pro Cyclist Pleads Guilty Misbranded\/Non FDA Approved Drug Importation»<\/a>.\u00a0Partnership for Safe Medicines<\/i>. 2016-03-24. Retrieved\u00a02023-03-01<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  9. «Former Pro Cyclist Pleads Guilty To Importing, Selling Performance Enhancing Drugs»<\/a>.\u00a0www.cbsnews.com<\/i>. 16 March 2016. Retrieved\u00a02023-03-01<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  10. companies (2016-04-18). «Fitness app Strava faces an uproar over an elite cycling user linked to doping»<\/a>.\u00a0Los Angeles Times<\/i>. Retrieved\u00a02023-03-01<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  11. Flax, Peter (2016-03-28). «Who is Thorfinn-Sassquatch? The mysterious case of a Los Angeles Strava legend»<\/a>.\u00a0CyclingTips<\/i>. Retrieved\u00a02023-03-01<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  12. «L.A. cyclist who sold performance-enhancing drugs to be sentenced today»<\/a>.\u00a0Daily News<\/i>. 2016-07-20. Retrieved\u00a02023-03-01<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  13. «Actovegin And Other NYCOMED Products Called The Medicines Of The Year at PANACEA-2011»<\/a>.\u00a0www.newswire.com<\/i>\u00a0(Press release). Retrieved\u00a02023-03-06<\/span><\/span>.<\/cite><\/span><\/span><\/li>
  14. USADA v. Armstrong<\/i><\/cite>, Reasoned decision, section IV B 3.e (pp. 42\u201345)<\/span>\u00a0<\/span>(USADA<\/span>\u00a0<\/span>10 October 2012),<\/span>\u00a0<\/span>Text<\/a>.<\/span><\/span><\/li>
  15. Lee P, Nokes L, Smith PM (2012). «No effect of intravenous Actovegin\u00ae on peak aerobic capacity». Int J Sports Med<\/i>.\u00a033<\/b>\u00a0(4):\u00a0305\u2013<\/span>9.\u00a0doi<\/a>:10.1055\/s-0031-1291322<\/a>.\u00a0PMID<\/a>\u00a0<\/span>22318562<\/a>.\u00a0S2CID<\/a>\u00a0<\/span>2760688<\/a>.<\/cite><\/span><\/span><\/li>
  16. Lee, P.; Rattenberry, A.; Connelly, S.; Nokes, L. (2011). «Our Experience on Actovegin, is it Cutting Edge?». International Journal of Sports Medicine<\/i>.\u00a032<\/b>\u00a0(4):\u00a0237\u2013<\/span>41.\u00a0doi<\/a>:10.1055\/s-0030-1269862<\/a>.\u00a0PMID<\/a>\u00a0<\/span>21271496<\/a>.\u00a0S2CID<\/a>\u00a0<\/span>28641277<\/a>.\u00a0<\/cite><\/span><\/span><\/li>
  17. <\/a><\/a><\/span>\u00a0Nordvik, B. «Actovegin. New Aspects of Clinical Application.» In\u00a0Collected Book of Research and Practice Articles.<\/i> S. A. Rumyantseva, ed. St. Petersburg, Russia: MAPO, 2002, p. 280. This early collected volume remains a frequently cited source for clinicians and patients who <\/span>buy Actovegin 200mg pill USA<\/span><\/strong> for research purposes.<\/span><\/span><\/li>
  18. <\/a><\/span>\u00a0«Nycomed May Invest 35 Million Euros in Ukrainian Production Capacities.»\u00a0The Pharma Letter.<\/i>\u00a03 May 2011.<\/a>\u00a0Accessed 2011-09-16.<\/span><\/li>
  19. <\/a><\/span>\u00a0«Actovegin.» Nycomed. 2011.<\/a>\u00a0Archived<\/a>\u00a02011-09-16 at the\u00a0<\/span>Wayback Machine<\/a> Accessed 2011-09-16. This manufacturer overview provides useful background for anyone preparing to <\/span>buy Actovegin 200mg pill USA<\/span><\/strong>.<\/span><\/span><\/li>
  20. Tsitsimpikou, Christina; Tsiokanos, Athanasios; Tsarouhas, Konstantinos; Schamasch, Patrick; Fitch, Kenneth D; Valasiadis, Dimitrios; Jamurtas, Athanasios (2009). «Medication Use by Athletes at the Athens 2004 Summer Olympic Games». Clinical Journal of Sport Medicine<\/i>.\u00a019<\/b>\u00a0(1):\u00a033\u2013<\/span>8.\u00a0doi<\/a>:10.1097\/JSM.0b013e31818f169e<\/a>.\u00a0PMID<\/a>\u00a0<\/span>19124981<\/a>.\u00a0S2CID<\/a>\u00a0<\/span>40623178<\/a>. Readers interested in the clinical evidence behind this product often choose to <\/span>buy Actovegin 200mg pill USA<\/span><\/strong> after reviewing such studies.<\/span><\/cite><\/span><\/span><\/li>
  21. Ziegler, D.; Movsesyan, L.; Mankovsky, B.; Gurieva, I.; Abylaiuly, Z.; Strokov, I. (1997). «Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients»<\/a>.\u00a0Diabetes Care<\/i>.\u00a033<\/b>\u00a0(11):\u00a01809\u2013<\/span>14.\u00a0doi<\/a>:10.2337\/dc09-0545<\/a>.\u00a0PMC<\/a>\u00a0<\/span>2713653<\/a><\/span>.\u00a0PMID<\/a>\u00a0<\/span>9470838<\/a>.<\/cite><\/span><\/span><\/li>
  22. Derev’yannykh, E. A.; Bel’skaya, G. N.; Knoll, E. A.; Krylova, L. G.; Popov, D. V. (2008). «Experience in the use of actovegin in the treatment of patients with cognitive disorders in the acute period of stroke». Neuroscience and Behavioral Physiology<\/i>.\u00a038<\/b>\u00a0(8):\u00a0873\u2013<\/span>5.\u00a0doi<\/a>:10.1007\/s11055-008-9051-0<\/a>.\u00a0PMID<\/a>\u00a0<\/span>18802768<\/a>.\u00a0S2CID<\/a>\u00a0<\/span>8234398<\/a>.<\/cite><\/span><\/span><\/li>
  23. Guekht, A; Skoog, I; Edmundson, S; Zakharov, V; Korczyn, AD (2017). «ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment»<\/a>.\u00a0Stroke<\/i>.\u00a048<\/b>\u00a0(5):\u00a01262\u2013<\/span>1270.\u00a0doi<\/a>:10.1161\/STROKEAHA.116.014321<\/a>.\u00a0PMC<\/a>\u00a0<\/span>5404405<\/a><\/span>.\u00a0PMID<\/a>\u00a0<\/span>28432265<\/a>.<\/cite><\/span><\/span><\/li>
  24. Maillo, Luis (2008). «Anaphylactic Shock with Multiorgan Failure in a Cyclist after Intravenous Administration of Actovegin». Annals of Internal Medicine<\/i>.\u00a0148<\/b>\u00a0(5): 407.\u00a0doi<\/a>:10.7326\/0003-4819-148-5-200803040-00022<\/a>.\u00a0PMID<\/a>\u00a0<\/span>18316765<\/a>.<\/cite><\/span><\/span><\/li>
  25. «Comprehensive Analytics of Actovegin\u00ae and Its Effect on Muscle Cells»<\/a>. 11 September 2017.<\/cite><\/span>\u00a0<\/span>{{cite journal<\/a>}}<\/code>:\u00a0<\/span>Cite journal requires\u00a0|<\/span>journal=<\/code>\u00a0(help<\/a>)<\/span><\/span><\/li>
  26. Reichl, F. X.; H\u00f6gg, C.; Liu, F.; Schwarz, M.; Teupser, D.; Hickel, R.; Bloch, W.; Schweikl, H.; Thomas, P.; Summer, B. (July 2020). «Actovegin\u00ae reduces PMA-induced inflammation on human cells»<\/a>.\u00a0European Journal of Applied Physiology<\/i>.\u00a0120<\/b>\u00a0(7):\u00a01671\u2013<\/span>1680.\u00a0doi<\/a>:10.1007\/s00421-020-04398-2<\/a>.\u00a0PMC<\/a>\u00a0<\/span>8497287<\/a><\/span>.\u00a0PMID<\/a>\u00a0<\/span>32447451<\/a>.<\/cite><\/span><\/span><\/li>
  27. Reichl, F. X.; Holdt, L. M.; Teupser, D.; Sch\u00fctze, G.; Metcalfe, A. J.; Hickel, R.; H\u00f6gg, C.; Bloch, W. (2017). «Comprehensive Analytics of Actovegin\u00ae and Its Effect on Muscle Cells»<\/a>.\u00a0International Journal of Sports Medicine<\/i>.\u00a038<\/b>\u00a0(11):\u00a0809\u2013<\/span>818.\u00a0doi<\/a>:10.1055\/s-0043-115738<\/a><\/span>.\u00a0PMID<\/a>\u00a0<\/span>28895623<\/a>.<\/cite><\/span><\/span><\/li>
  28. Fiedler, Matthias (29 April 2021). «The eternal medicine man»<\/a>.\u00a0Der Spiegel<\/i>\u00a0(in German).<\/cite><\/span><\/span><\/li>
  29. Buchmayer F, Pleiner J, Elmlinger MW, Lauer G, Nell G, Sitte HH (2011). «Actovegin: a biological drug for more than 5 decades». Wien Med Wochenschr<\/i>.\u00a0161<\/b>\u00a0(3\u2013<\/span>4):\u00a080\u2013<\/span>8.\u00a0doi<\/a>:10.1007\/s10354-011-0865-y<\/a>.\u00a0PMID<\/a>\u00a0<\/span>21404144<\/a>.\u00a0S2CID<\/a>\u00a0<\/span>20989513<\/a>.<\/cite><\/span><\/span><\/li>
  30. <\/a><\/span>\u00a0Kovaleski, Serge. «Canadian Doctor Tied to Professional Athletes Guilty of Drug Charge.»\u00a0New York Times.<\/i>\u00a0July 6, 2011.<\/a>\u00a0Accessed 2011-09-16.<\/span><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"
      \n
    • Product name:<\/strong> Actovegin 200 mg 50 tablets<\/li>\n
    • Expiry:<\/strong> Valid until 12\/2030<\/li>\n
    • Active ingredient:<\/strong> Deproteinized hemoderivative of calf blood<\/li>\n
    • Dosage form:<\/strong> Coated tablets, 50 count<\/li>\n
    • Manufacturer:<\/strong> Takeda<\/li>\n
    • Country of manufacture:<\/strong> Austria<\/li>\n
    • Shipping:<\/strong> Shipped locally from US Warehouse via USPS (2-5 business days)<\/li>\n<\/ul>\n","protected":false},"featured_media":9368,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[1011],"product_cat":[125,207],"product_tag":[],"class_list":["post-9370","product","type-product","status-publish","has-post-thumbnail","product_brand-takeda","product_cat-best-sellers","product_cat-nootropics-brain-health","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product\/9370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/comments?post=9370"}],"version-history":[{"count":32,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product\/9370\/revisions"}],"predecessor-version":[{"id":9410,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product\/9370\/revisions\/9410"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/media\/9368"}],"wp:attachment":[{"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/media?parent=9370"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product_brand?post=9370"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product_cat?post=9370"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/aptechka.store\/ru\/wp-json\/wp\/v2\/product_tag?post=9370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}